Spravato®

Active substance

Holder

Status

Closed

Indication

In combination with a SSRI or SNRI, for treatment-resistant depression (Major Depressive

Disorder) in adults who have not responded to at least two different treatments with antidepressants in

the current moderate to severe depressive episode

Public documents

Approbation

Information for the patient

Informed consent

Last update